Calendar

An AMCP Webinar

Whether you're a student pharmacist exploring career possibilities, a resident or fellow planning your next step, a pharmacist considering a career transition, or a managed care pharmacy professional looking to deepen your perspective and share the value of our profession with others, this webinar is for you.

Join AMCP and the Membership Committee for an engaging overview of managed care pharmacy and the vital role it plays in improving patient access to medications, supporting evidence-based care, and helping navigate today's complex healthcare landscape.

An AMCP LINK Group Webinar.

The 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome is the first guideline written jointly by the heart, cardiology, diabetes, and kidney societies—and it cuts across nearly every silo a health plan is organized around. In this kickoff webinar for AMCP's Metabolic Health LINK, we'll unpack the changes with the greatest impact on managed care pharmacy, including staging, risk calculation, therapy selection by comorbidity, and where obesity medications now sit within benefit design. A payer panel will then work through the real-world coverage, clinical, and operational questions plans are facing as these frameworks take hold. Join us to connect with peers and help shape how managed care responds to the evolving management of metabolic health holistically.

A Pre-Approval Information Exchange (PIE) Webinar, presented by Bayer.

Recurrent non-cardioembolic ischemic stroke and TIA are a growing population health concern. This webinar is a discussion for formulary decision makers that addresses the recurrent stroke and TIA landscape and offers a clinical overview of an investigational drug and includes the results from the phase 3 clinical study OCEANIC-STROKE.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have note been established.

A Science & Innovation Webinar, presented by Abbvie.

It is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy. One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal.

Dr. Maureen Moriarty, a migraine expert, will:

• Discuss the complexity of migraine disease and the burden of the disease as it relates to function.

• Discuss the treatment guidelines for preventive treatment of migraine, with a focus on a treatment option with updated clinical data for migraine prevention.

A Science & Innovation Webinar, presented by Abbvie.

One of the primary goals of acute treatment of migraine is rapid and consistent freedom from pain and most bothersome associated symptoms without recurrence. Regardless of migraine frequency or time of month, it is important that every appropriate person with migraine be offered a treatment for migraine. Notably, over 50% of females with migraine disease experience migraine attacks around menstruation, which can be more severe, and longer-lasting than those occurring at other times of the month. The objective for this webinar is to review the migraine disease state and outline the clinical data for an acute treatment of migraine attacks, including data around the perimenstrual period.

Dr. Deena Kuruvilla, a headache specialist, will:

• Discuss the complexity of migraine disease and the burden of the disease as it relates to function.
• Discuss an acute treatment option for migraine in adults.